The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
{{output}}
Three-dimensional (3D) epigenome remodeling is an important mechanism of gene deregulation in cancer. However, its potential as a target to counteract therapy resistance remains largely unaddressed. Here, we show that epigenetic therapy with decitabine (5-Aza-... ...
